It announced that earnings in the second quarter are expected to be between 68-72 cents a share, which is down from the original forecast of 77 to 82 cents.
The company said it now expects second-quarter earnings of 68 cents and 72 cents a share, down from its prior outlook of 77 cents to 82 cents.
The findings are published in the November 6 edition of the journal Nature .